Medpace Holdings, Inc.

NASDAQ:MEDP

Medical - Diagnostics & Research

Healthcare
$646.87 -0.98%

-$4.51 today

Market cap
$18.09B
Beta
1.18
P/E (TTM)
28.2
EPS (TTM)
$16.19
52W Low $301.90High $628.92

Volume 0.21M

Average 0.36M

MEDP Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Medpace Holdings, Inc.NASDAQ: MEDP

Retained Earnings · Q3 FY2026 · quarter ended Sep 2026

Retained earnings remains negative

Q3 FY2026 retained earnings was -$373.57M, compared with -$596.24M a year earlier.

Context

  • Retained earnings amounted to 16.2% of total assets at the end of Q3 FY2026, down 17.8 pp from a year earlier.
  • Retained earnings increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether retained earnings keeps rising in the next quarterly balance sheet after a +37.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$373.57M+26.9% QoQ
Last fiscal yearDec 2025
-$459.98M-5732.2% YoY
Year agoSep 2025
-$596.24M+37.3% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+37.3%——
1 year-5732.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2025
(459.98M) USD
Year-over-year change
-5732.2%

Retained Earnings vs competitors

How MEDP compares with its peers on the latest reported figures

  • MEDP's Sep 2026 retained earnings of -$373.57M is the 4th highest of the 5 companies compared; the peer median is $1.84B.
  • Its year-over-year change of +37.3% is the highest of 5, against a peer median of -8.3%.
  • Retained earnings amounts to 16.2% of total assets for MEDP, versus a peer median of 22.4%.
MEDP Competitors Peer median
Retained Earnings for MEDP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
IQVIQVIA Holdings Inc.Jun 2026$7.96B +20.9%+30.6%26.6%
ICLRICON Public Limited CompanyJun 2026$2.3B -10.2%+5.2%14.0%
CRLCharles River Laboratories International, Inc.Jun 2026$1.37B -27.4%-1.0%18.2%
MEDPMedpace Holdings, Inc.Sep 2026-$373.57M +37.3%—16.2%
FTREFortrea Holdings Inc.Jun 2026-$1.42B -6.4%—52.3%
Peer median (excluding MEDP) $1.84B-8.3%+5.2%22.4%

Competitors are the stored peer set for MEDP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents461.3M28.27M245.45M669.44M497.05M
Short-term Investments00000
Net Receivables186.43M253.4M298.4M296.44M402.08M
Inventory00000
Other Current Assets052.29M49.98M63.35M90.5M
Total Current Assets690.91M333.96M593.83M1.03B989.62M
Property, Plant & Equipment (Net)222.71M248.92M265.39M252.26M248.87M
Goodwill662.4M662.4M662.4M662.4M662.4M
Intangible Assets41.36M38.01M35.81M34.37M33.42M
Long-term Investments00000
Tax Assets25.13M48.08M74.44M100.36M19.22M
Other Non-current Assets17.42M21.13M24.97M22.25M21.94M
Total Non-current Assets969.02M1.02B1.06B1.07B985.85M
Total Assets1.66B1.35B1.66B2.1B1.98B
Account Payables25.68M33.07M31.87M32.53M28.14M
Short-term Debt050M000
Tax Payables00000
Deferred Revenue344.64M462.73M559.86M710.59M854.39M
Other Current Liabilities11.34M15.78M18.08M30.34M29.63M
Total Current Liabilities557.22M803.47M925.13M1.1B1.34B
Long-term Debt00000
Deferred Tax Liabilities1.08M1.07M2.4M1.8M1.36M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities17.75M22.7M28.22M42.73M57.66M
Total Non-current Liabilities149.79M162.64M172.75M170.77M172.65M
Total Liabilities707.01M966.11M1.1B1.28B1.52B
Common Stock360K309K308K306K284K
Retained Earnings234.98M(359.83M)(221.65M)8.17M(459.98M)
Accumulated OCI(4.85M)(12.39M)(10.07M)(14.74M)(4.91M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity952.93M386.39M558.95M825.55M459.07M
Total Debt147.24M208.14M164.49M149.52M136.85M
Net Debt(314.06M)179.87M(80.96M)(519.91M)(360.2M)

Medpace Holdings, Inc.

NASDAQ:MEDP

Intrinsic Alpha fair value

Locked

Current Price

$646.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.